Navigation Links
P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company
Date:1/31/2008

CINCINNATI, Jan. 31, 2008 /PRNewswire-FirstCall/ -- The Procter & Gamble Company (NYSE: PG) announced net sales growth of nine percent to $21.6 billion for the quarter. Sales were up behind strong volume growth from continued success on key product initiatives and double-digit organic growth in developing regions. Organic volume increased six percent and organic sales were up five percent for the quarter. Diluted earnings per share increased 17 percent to $0.98 per share, above the top end of the company's $0.95 to $0.97 per share guidance range. Earnings grew as topline growth and continued Gillette synergy benefits more than offset higher commodity costs.

"This quarter is another demonstration of P&G's capability to deliver strong results in a difficult competitive and commodity cost environment," said A.G. Lafley, Chairman of the Board and Chief Executive Officer. "Solid topline growth and a sharp focus on cost control are driving strong profit and cash generation. Looking ahead, we are confident that the strength of the company's brand portfolio, initiative pipeline and productivity program will enable P&G to continue delivering at or ahead of its targets."

Executive Summary

-- Net sales increased nine percent to $21.6 billion behind six percent

organic volume growth. Every geographic region posted year-on-year

organic volume growth, led by double-digit growth in developing

regions.

-- Net Earnings grew 14 percent to $3.3 billion primarily behind the

combination of sales growth and overhead cost savings, which more than

offset the impact of higher commodity costs. Earnings per share

increased 17 percent to $0.98 for the quarter.

-- Operatin
'/>"/>

SOURCE The Procter & Gamble Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. Nutraceutical Reports Fiscal 2008 Q1 Results
2. Matrixx Initiatives, Inc. Reports Fiscal 3rd Quarter Net Sales of $30.8 Million and Net Loss of ($0.07) Per Share
3. Accuray Reports Continued Growth in Second Quarter of Fiscal 2008
4. Cardinal Health Reports Second Quarter Results, Revises EPS Outlook
5. Encision Reports Third Fiscal Quarter Results
6. Zimmer Reports Fourth Quarter and 2007 Financial Results
7. Amylin Pharmaceuticals Reports 2007 Financial Results
8. Cystic Fibrosis Foundation reports upward trend for key health outcomes
9. NBTY Reports First Quarter Results
10. Moog Reports 14% Increase in Earnings Per Share
11. Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...elps Organizations Meet HIPAA Compliance Requireme...ligibility, , (PRWEB) Nov...ing provider of high-performance data integration ...e launch of new products within its healthcare int...er healthcare organizations meet industry standard...
(Date:11/23/2009)... chances, while both increased risk eightfold , ...dren whose mothers smoked during pregnancy or who ...k of having attention-deficit hyperactivity disord..., And with exposure to both cigarettes and lead,... mothers smoked during pregnancy and whose blood s...
(Date:11/23/2009)...PRNewswire-FirstCall/--NewCardio,Inc.,(OTCBulletin...nouncedtodaythatCEO,Dr.BranislavVajdic,andCFO,Rich...erenceonThursday,December3rd,at4:30PMPSTattheLuxeS...lbeavailableforone-on-onemeetingsonWednesday,Decem...meeMaasat(646)536-7331or brett@haydenir.com torequ...
(Date:11/23/2009)...zed as Best New Technology Provider for its QlikVi... Radnor, PA (PRWEB) November 23, 2009 --...ess Intelligence (BI) software company, today anno...T Innovation™ Award in the Best New Technolo...kView. The award was presented at Everything Chann...
(Date:11/23/2009).../PRNewswire/--Thistimeofyearbringslotsofcheerbutal...s,bothpositiveandnegative,translateintourgestoover...ortunitiestodosoallseasonlong. ,, Wemaythinkwea...yofusstopthere?"Thatpieoftenopensthefloodgatestocr...ayseasontellingourselvestohavejustonelittletreat.I...
Breaking Medicine News(10 mins):Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 2Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 3Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 4Health News:Smoking During Pregnancy, Lead Exposure Raise ADHD Risk in Kids 2Health News:Smoking During Pregnancy, Lead Exposure Raise ADHD Risk in Kids 3Health News:NewCardio, Inc. to Present at 2nd Annual LD MICRO Conference 2Health News:NewCardio, Inc. to Present at 2nd Annual LD MICRO Conference 3Health News:QlikTech Wins Healthcare IT Innovation™ Award 2Health News:QlikTech Wins Healthcare IT Innovation™ Award 3Health News:QlikTech Wins Healthcare IT Innovation™ Award 4Health News:Tis' the Season to Eat and Eat More! 2
...s should be mindful of the possible interaction be...mmended by the Federal Centers for Disease Control...cently recommended that antibiotic and anti-infect...s are known to interfere with the efficacy of oral...
...s of flu. These days, people fear the symptoms cou...ng to wait in hours-long lines to get a shot of in... the flu and anthrax panic. "We're getting a treme...e New York. "People are anxious to get it, and I t...
...irus that kills at least 30 percent of its victims...rom the globe more than two decades ago. Scientist...es the disease, and stored them in secure laborato...ening," said Dr. Anthony Fauci, director of the Na...
...tion time and improve performance for military ser... help staying alert for longer periods of time, ac... Sciences. The report, by the academy's Institute ...in times of sleep deprivation. // A simila...
...al of a new anti-cancer drug interacts with speci.... Ceflatonin, a natural product, is being tested a...any ChemGenex is looking at the effect of the drug...n done in human colon cancer cells and on tumour g...
...ple, researchers have uncovered a strong link betw...ate, Zhang and colleagues analyzed the relationshi...mory impairment among more than 4,300 elderly peop...erbal memory. "Verbal memory impairment is one of ...
Other Medicine News:
(Date:11/20/2009)...ISBURG, Pa., Nov. 20 Th...H1N1 flu shots to members of priority groups that ... A total of 18 clinics are being held statewide on... to 8 p.m. Hours on Saturday, Nov. 21, will be 8 a... operate from 2 p.m. to 8 p.m. ,, Individuals ...
(Date:11/20/2009)...EW YORK, Nov. 20 ,, Reportlink... is available in its catalogue. ,, India Medic... ,, http://www.reportlinker.com/p0164658/Ind...-to-2015.html#utm_source=prnewswire&utm_medium...on ,, India Medical Equipment Market Analysis ...
(Date:11/20/2009)...CK, Mass. and LONDON, Nov. 20 /PRNewswire-FirstCal... today announced that it has received 510(k) clear...DA) and CE Mark approval to market its WallFlex...nt of malignant esophageal strictures (obstruction... non-resectable esophageal cancer. ,, (Photo: ...
Breaking Medicine Technology:Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 2Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 3Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 4Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 5Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 6Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 7Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 8Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 9Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 10Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 11Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 12Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 13Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 13364 1Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 13364 2Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 13364 3Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 13364 4Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 13364 5Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 13364 6Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 13364 7Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update 13364 8Keryx Biopharmaceuticals Inc to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday August 6 2009 at 8 3A30am EDT 13361 1Keryx Biopharmaceuticals Inc to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday August 6 2009 at 8 3A30am EDT 13361 2ARUP Laboratories Applauds FDAs Decision on the Value of KRAS Mutation Testing in Colorectal Cancer 4822 1ARUP Laboratories Applauds FDAs Decision on the Value of KRAS Mutation Testing in Colorectal Cancer 4822 2ARUP Laboratories Applauds FDAs Decision on the Value of KRAS Mutation Testing in Colorectal Cancer 4822 3
...a was presented by Nektar Therapeutics (Nasdaq: N...NKTR-102 (PEG-irinotecan), which demonstrated,enha...l of colorectal,cancer when co-administered with b...for Cancer Research (AACR) Annual Meeting 2008 in ...nhanced pharmacokinetic profile and,tolerability o...
...onstrate Significant Tumor Growth Inhibiti...O, Calif., April 14 Intradigm Corporation, a,lead...ce (RNAi),therapeutics, today announced study resu...(NPX) delivery technology platform is capable of e...As) targeting both vascular,endothelial growth fac...
Other Medicine Technology:Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting 2Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting 3Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting 4Additive Anti-Tumor Activity of NKTR-102 in Combination With Bevacizumab Highlighted in Positive Preclinical Data Presented at AACR Meeting 5Study Shows Intradigm's RNAi Nanoplex Technology To Be Effective Systemic siRNA Delivery Platform for the Treatment of Various Cancer Models 2Study Shows Intradigm's RNAi Nanoplex Technology To Be Effective Systemic siRNA Delivery Platform for the Treatment of Various Cancer Models 3
...lmer platelet agitators offer a wide range of stor...e drawer storage platform to agitate smoothly, eli...n and squeak. Sturdy, one-piece perforated drawers...r circulation for your platelets., ,i.Series p...
Platelet Agitator 4722
Reciprocating Platelet Shaker TPS-32
Progesterone RIA Kit
Medicine Products: